Rybelsus was the first oral GLP-1 approved for diabetes, available in 3mg, 7mg, and 14mg daily tablets
Major medical sources note very limited research on lipotropic injections for weight loss, and that any weight change is often more attributable to the overall program (nutrition, activity, calorie intake) than the injection alone
In brief, SUSTAIN 6 was a randomized, double-blind, placebo-controlled, parallel-group trial to evaluate once-weekly semaglutide 0.5 or 1.0 mg vs volume-matched placebo over a 104-week treatment period plus a 5-week follow-up period
We follow a clear plan to build understanding, boost confidence, and encourage long-term results
You complete a short online intake about your health and goals